Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid
Clinical trial NCT01701999 · COMPLETED
Trial details
- NCT number
- NCT01701999
- Sponsor
- California Department of Public Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2015-06-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.